Drugmakers, trade groups and others voice concerns with pharma-specific tariffs

29th May 2025 Uncategorised 0

Some two weeks after the public comment period closed for the Trump administration’s Section 232 investigation into the national security implications of pharmaceutical imports, a wide range of drugmakers, trade groups and foreign governments have largely aligned in opposition to potential industry-specific tariffs.

More: Drugmakers, trade groups and others voice concerns with pharma-specific tariffs
Source: fierce